ArticleAmerican journal of cancer research2021

A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers.

Bashir Lawal et al.PubMed ↗Full text ↗

No numbers read from the abstract.